Research Article

The Clinical and Genetic Characteristics in Children with Idiopathic Hypogonadotropin Hypogonadism

Table 4

Further genetic pathogenicity analysis of 12 children with IHH (excluding benign or likely benign variants).

CaseGeneVariantAmino acidSource of variantMutation tasterCADD_rawCADD_phredMetaSVM_scoreClassification (ACMG)

KS1CHD7c.2442+1G>A/De novo1///P (PVS1, PS2, PM2, PP3, PP4)
KS2CHD7c.2744A>Gp.D915GPaternal0.9994.436320.31LP (PM1, PM2, PP3, PP4)
KS4CHD7c.2698-1G>T/Paternal1///P (PVS1, PM2, PP3)
KS5CHD7c.2724G>Tp.W908CMaternal14.566321.068LP (PM1, PM2, PP3, PP4)
KS6NDNFc.1439T>Ap.I480NPaternal0.9994.09428.50.508US (PM2, PP2, PP3)
nHH1CHD7c.749G>Ap.R250HPaternal0.9993.505250.08US (PP3, PP4)
nHH3CHD7c.59G>Ap.G20DMaternal0.9862.86523.31.045US (PP3, PP4)
nHH4CHD7c.2182G>Ap.D728NPaternal0.9992.81923.20.488US (PP3, PP4)
nHH5FGFR1c.1271G>Ap.R424HPaternal0.9993.48924.90.062US (PM2, PP3, PP4)
SEMA3Ac.1369A>Gp.T457AMaternal0.9993.67225.61.111US (PM2, PP2, PP3, PP5, PP6)
nHH6FGF8c.368G>Ap.G123EMaternal0.9993.81226.31.017US (PM2, PP3, PP6)
nHH7PROKR2c.891_892insAp.R298Tfs2Paternal////P (PVS1, PM2, PM4, PP4)
nHH8CHD7c.4153G>Cp.D1385HDe novo0.9994.305311.004P (PS2, PM1, PM2, PP3, PP4)

: Splice Site Score Calculation and SpliceAI for Splicing Sites: Test positive. The 12 variants predicted by MutationTaster are all classified as "pathogenic". CADD_raw is the initial score, and CADD_phred is the converted score. The higher the score, the greater the harmful effect.The CADD_phred score is recommended to be greater than 15. MetaSVM fractional cut value is 0.0 (higher score indicates greater harmful effects). ACMG: American College of Medical Genetics Laboratory Practice Committee Working Group, Described as P:pathogenic; LP:likely pathogenic; US: uncertain significance. B: benign ;LB: likely benign. PVS: pathogenic very strong, PS: pathogenic strong, PM: pathogenic moderate,PP: pathogenic supporting.